Remedium Lifecare surges on planning to increase borrowing limit by issuance of debt securities
Remedium Lifecare is currently trading at Rs. 2908.10, up by 57.70 points or 2.02% from its previous closing of Rs. 2850.40 on the BSE.
The scrip opened at Rs. 2840.60 and has touched a high and low of Rs. 2949.95 and Rs. 2838.00 respectively. So far 854 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 3139.60 on 14-Jun-2023 and a 52 week low of Rs. 134.50 on 20-Jun-2022.
Last one week high and low of the scrip stood at Rs. 3139.60 and Rs. 2260.00 respectively. The current market cap of the company is Rs. 1046.92 crore.
The promoters holding in the company stood at 1.11%, while Non-Institutions held 98.89% stake in the company.
Remedium Lifecare is planning to increase borrowing limit from Rs 50 crore to Rs 1000 crore by issuance of debt securities ie. Non -Convertible Debentures(NCD), Bank Term Loans etc. The company is also planning to consider and approve limit for investment by way of acquisition of Asset such as Plant &, Machinery, securities, etc upto Rs 1000 crore. The meeting of the Board of Directors of the Company is scheduled to be held on June 23, 2023 to consider the same.
Remedium Lifecare is pharmaceutical company aligned across two business verticals viz. Products and Services.
